These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33319329)

  • 21. Characterization of spray dried powders with nucleic acid-containing PEI nanoparticles.
    Keil TWM; Feldmann DP; Costabile G; Zhong Q; da Rocha S; Merkel OM
    Eur J Pharm Biopharm; 2019 Oct; 143():61-69. PubMed ID: 31445157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-spray dried carbohydrate microparticles: crystallisation delay/inhibition and improved aerosolization characteristics through the incorporation of hydroxypropyl-β-cyclodextrin with amorphous raffinose or trehalose.
    Amaro MI; Tajber L; Corrigan OI; Healy AM
    Pharm Res; 2015 Jan; 32(1):180-95. PubMed ID: 25074469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of disaccharides alone and in combination, for the improvement of stability and particle properties of spray-freeze dried IgG.
    Daneshmand B; Faghihi H; Amini Pouya M; Aghababaie S; Darabi M; Vatanara A
    Pharm Dev Technol; 2019 Apr; 24(4):439-447. PubMed ID: 30070161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of excipients on physical and aerosolization stability of spray dried high-dose powder formulations for inhalation.
    Shetty N; Park H; Zemlyanov D; Mangal S; Bhujbal S; Zhou QT
    Int J Pharm; 2018 Jun; 544(1):222-234. PubMed ID: 29678544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Raman mapping of mannitol/lysozyme particles produced via spray drying and single droplet drying.
    Pajander JP; Matero S; Sloth J; Wan F; Rantanen J; Yang M
    Pharm Res; 2015 Jun; 32(6):1993-2002. PubMed ID: 25504535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spray-freeze-drying of nanosuspensions: the manufacture of insulin particles for needle-free ballistic powder delivery.
    Schiffter H; Condliffe J; Vonhoff S
    J R Soc Interface; 2010 Aug; 7 Suppl 4(Suppl 4):S483-500. PubMed ID: 20519207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trehalose Limits Fragment Antibody Aggregation and Influences Charge Variant Formation in Spray-Dried Formulations at Elevated Temperatures.
    Rajagopal K; Chang D; Nayak P; Izadi S; Patapoff T; Zhang J; Kelley R; Sreedhara A
    Mol Pharm; 2019 Jan; 16(1):349-358. PubMed ID: 30525659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of process variables on the powder yield of spray-dried trehalose on a laboratory spray-dryer.
    Maury M; Murphy K; Kumar S; Shi L; Lee G
    Eur J Pharm Biopharm; 2005 Apr; 59(3):565-73. PubMed ID: 15760738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancing the viability of Lactobacillus rhamnosus GG after spray drying and during storage.
    Broeckx G; Vandenheuvel D; Henkens T; Kiekens S; van den Broek MFL; Lebeer S; Kiekens F
    Int J Pharm; 2017 Dec; 534(1-2):35-41. PubMed ID: 28986319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spray-Freeze Drying: a Suitable Method for Aerosol Delivery of Antibodies in the Presence of Trehalose and Cyclodextrins.
    Pouya MA; Daneshmand B; Aghababaie S; Faghihi H; Vatanara A
    AAPS PharmSciTech; 2018 Jul; 19(5):2247-2254. PubMed ID: 29740758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing freeze drying and spray drying of interleukins using model protein CXCL8 and its variants.
    Fiedler D; Hartl S; Gerlza T; Trojacher C; Kungl A; Khinast J; Roblegg E
    Eur J Pharm Biopharm; 2021 Nov; 168():152-165. PubMed ID: 34474111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Freeze drying of human serum albumin (HSA) nanoparticles with different excipients.
    Anhorn MG; Mahler HC; Langer K
    Int J Pharm; 2008 Nov; 363(1-2):162-9. PubMed ID: 18672043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct effects of sucrose and trehalose on protein stability during supercritical fluid drying and freeze-drying.
    Jovanović N; Bouchard A; Hofland GW; Witkamp GJ; Crommelin DJ; Jiskoot W
    Eur J Pharm Sci; 2006 Mar; 27(4):336-45. PubMed ID: 16338123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding the Impact of Protein-Excipient Interactions on Physical Stability of Spray-Dried Protein Solids.
    Chen Y; Ling J; Li M; Su Y; Arte KS; Mutukuri TT; Taylor LS; Munson EJ; Topp EM; Zhou QT
    Mol Pharm; 2021 Jul; 18(7):2657-2668. PubMed ID: 34096731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of operating and formulation variables on the morphology of spray-dried protein particles.
    Maa YF; Costantino HR; Nguyen PA; Hsu CC
    Pharm Dev Technol; 1997 Aug; 2(3):213-23. PubMed ID: 9552449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants.
    Cheow WS; Ng ML; Kho K; Hadinoto K
    Int J Pharm; 2011 Feb; 404(1-2):289-300. PubMed ID: 21093560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of excipients for enhanced thermal stabilization of a human type 5 adenoviral vector through spray drying.
    LeClair DA; Cranston ED; Xing Z; Thompson MR
    Int J Pharm; 2016 Jun; 506(1-2):289-301. PubMed ID: 27130366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A user-friendly model for spray drying to aid pharmaceutical product development.
    Grasmeijer N; de Waard H; Hinrichs WL; Frijlink HW
    PLoS One; 2013; 8(9):e74403. PubMed ID: 24040240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conformational analysis of protein secondary structure during spray-drying of antibody/mannitol formulations.
    Schüle S; Friess W; Bechtold-Peters K; Garidel P
    Eur J Pharm Biopharm; 2007 Jan; 65(1):1-9. PubMed ID: 17034996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physical and immunogenic stability of spray freeze-dried influenza vaccine powder for pulmonary delivery: comparison of inulin, dextran, or a mixture of dextran and trehalose as protectants.
    Murugappan S; Patil HP; Kanojia G; ter Veer W; Meijerhof T; Frijlink HW; Huckriede A; Hinrichs WL
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):716-25. PubMed ID: 23933147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.